Marshall-Andon Tess, Heinz Peter
School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Cambridge University Hospitals NHS Foundation Trust, Department of Paediatrics, Addenbrooke's Hospital, Cambridge, UK.
Arch Dis Child Educ Pract Ed. 2017 Aug;102(4):188-193. doi: 10.1136/archdischild-2016-311526. Epub 2017 Jan 27.
Epstein-Barr virus (EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection in children but frequently results in infectious mononucleosis in adolescents. Heterophile antibody tests, including the Monospot test, are red cell or latex agglutination assays, which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV infection. Heterophile antibody tests are rapid, cheap and specific tests that can be performed from the onset of symptoms of infectious mononucleosis. In adolescents, heterophile antibody tests have high specificity and sensitivity in the diagnosis of primary acute EBV infection. However, the tests have low sensitivity and low negative predictive value in young children and are not useful under the age of 4. Heterophile tests may be positive in other viral infections, autoimmune disease and haematological malignancies, but do not appear to be positive in primary bacterial infection. Virus-specific serology is required in children under the age of 4 or if an older child is heterophile negative. Virus-specific serology allows diagnosis and the pattern of positivity and negativity enables the clinician to stage the EBV infection. Virus-specific serology appears to have better sensitivity in young children, but there is cross-reaction with other herpesvirus infections, a longer turnaround time and it is more expensive to perform. Further research is needed to establish which children benefit from and hence require testing for heterophile antibodies, the cost-effectiveness of EBV investigations and whether heterophile titres have predictive value for the severity of infection and the likelihood of complications.
爱泼斯坦-巴尔病毒(EBV)是一种高度流行的病毒,通过唾液传播,它在儿童中常引起无症状感染,但在青少年中常导致传染性单核细胞增多症。嗜异性抗体检测,包括嗜异凝集试验,是红细胞或乳胶凝集试验,可检测作为EBV感染期间发生的多克隆抗体反应一部分而产生的抗红细胞抗体。嗜异性抗体检测是快速、廉价且特异的检测方法,可在传染性单核细胞增多症症状出现时进行。在青少年中,嗜异性抗体检测对原发性急性EBV感染的诊断具有高特异性和敏感性。然而,该检测在幼儿中的敏感性低且阴性预测值低,在4岁以下儿童中无用。嗜异性检测在其他病毒感染、自身免疫性疾病和血液系统恶性肿瘤中可能呈阳性,但在原发性细菌感染中似乎不呈阳性。4岁以下儿童或年龄较大儿童嗜异性检测呈阴性时需要进行病毒特异性血清学检测。病毒特异性血清学检测可用于诊断,其阳性和阴性模式可使临床医生对EBV感染进行分期。病毒特异性血清学检测在幼儿中似乎具有更好的敏感性,但与其他疱疹病毒感染存在交叉反应,周转时间较长且检测费用更高。需要进一步研究以确定哪些儿童可从嗜异性抗体检测中获益并因此需要进行检测、EBV检测的成本效益以及嗜异性抗体滴度对感染严重程度和并发症可能性是否具有预测价值。